Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 3
1 March 1998
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Review

Update on endocrine therapy for breast cancer.
A U Buzdar; G Hortobagyi
View articletitled, Update on endocrine therapy for breast cancer.
Open the PDF for in another window

Advances in Brief

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
D H Lee; S C Yang; S J Hong; B H Chung; I Y Kim
View articletitled, Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Open the PDF for in another window
Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
V A Papadimitrakopoulou; Y Oh; A El-Naggar; J Izzo; G Clayman; L Mao
View articletitled, Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Open the PDF for in another window
Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
L Liebes; M Potmesil; T Kim; D Pease; M Buckley; D Fry; J Cho; H Adler; K Dar; A Zeleniuch-Jacquotte; H Hochster
View articletitled, Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Open the PDF for in another window

Research Articles

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.
L L Siu; D Banerjee; R J Khurana; X Pan; R Pflueger; I F Tannock; M J Moore
View articletitled, The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.
Open the PDF for in another window
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
C Wang; A D Thor; D H Moore, 2nd; Y Zhao; R Kerschmann; R Stern; P H Watson; E A Turley
View articletitled, The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
Open the PDF for in another window
Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
M Torzewski; M Sarbia; H Heep; P Dutkowski; R Willers; H E Gabbert
View articletitled, Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Open the PDF for in another window
Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
A J Troy; K L Summers; P J Davidson; C H Atkinson; D N Hart
View articletitled, Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
Open the PDF for in another window
Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks.
S G Eckhardt; S D Baker; J R Eckardt; T G Burke; D L Warner; J G Kuhn; G Rodriguez; S Fields; A Thurman; L Smith; M L Rothenberg; L White; P Wissel; R Kunka; S DePee; D Littlefield; H A Burris; D D Von Hoff; E K Rowinsky
View articletitled, Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks.
Open the PDF for in another window
A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.
A C McDonald; P A Vasey; L Adams; J Walling; J R Woodworth; T Abrahams; S McCarthy; N P Bailey; N Siddiqui; M J Lind; A H Calvert; C J Twelves; J Cassidy; S B Kaye
View articletitled, A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.
Open the PDF for in another window
Phase Ib trial of bryostatin 1 in patients with refractory malignancies.
S Grant; J Roberts; E Poplin; M B Tombes; B Kyle; D Welch; M Carr; H D Bear
View articletitled, Phase Ib trial of bryostatin 1 in patients with refractory malignancies.
Open the PDF for in another window
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
O Eton; D D Kharkevitch; M A Gianan; M I Ross; K Itoh; M W Pride; C Donawho; A C Buzaid; P F Mansfield; J E Lee; S S Legha; C Plager; N E Papadopoulos; A Y Bedikian; R S Benjamin; C M Balch
View articletitled, Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Open the PDF for in another window
Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.
B A Conley; M J Egorin; N Tait; D M Rosen; E A Sausville; G Dover; R J Fram; D A Van Echo
View articletitled, Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.
Open the PDF for in another window
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
G T Budd; P C Adamson; M Gupta; P Homayoun; S K Sandstrom; R F Murphy; D McLain; L Tuason; D Peereboom; R M Bukowski; R Ganapathi
View articletitled, Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Open the PDF for in another window
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
S F Slovin; H I Scher; C R Divgi; V Reuter; G Sgouros; M Moore; K Weingard; R Pettengall; M Imbriaco; A El-Shirbiny; R Finn; J Bronstein; C Brett; D Milenic; A Dnistrian; L Shapiro; J Schlom; S M Larson
View articletitled, Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Open the PDF for in another window
Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.
F Albertioni; S Lindemalm; V Reichelova; B Pettersson; S Eriksson; G Juliusson; J Liliemark
View articletitled, Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.
Open the PDF for in another window
Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.
M Toi; T Taniguchi; T Ueno; M Asano; N Funata; K Sekiguchi; H Iwanari; T Tominaga
View articletitled, Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.
Open the PDF for in another window
Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
A Mutirangura; W Pornthanakasem; A Theamboonlers; V Sriuranpong; P Lertsanguansinchi; S Yenrudi; N Voravud; P Supiyaphun; Y Poovorawan
View articletitled, Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Open the PDF for in another window
Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
I Bièche; V Lazar; C Noguès; T Poynard; Y Giovangrandi; D Bellet; R Lidereau; M Vidaud
View articletitled, Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
Open the PDF for in another window
Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
Y Shibamoto; O Ike; H Mizuno; T Fukuse; S Hitomi; M Takahashi
View articletitled, Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
Open the PDF for in another window
Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.
A A Adjei; M Charron; E K Rowinsky; P A Svingen; J Miller; J M Reid; J Sebolt-Leopold; M M Ames; S H Kaufmann
View articletitled, Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.
Open the PDF for in another window
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
S M Melana; J F Holland; B G Pogo
View articletitled, Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Open the PDF for in another window
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
S W McLeskey; L Zhang; D El-Ashry; B J Trock; C A Lopez; S Kharbanda; C A Tobias; L A Lorant; R S Hannum; R B Dickson; F G Kern
View articletitled, Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
Open the PDF for in another window
Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
S Mogi; T Ebata; Y Setoguchi; M Fujime; Y Heike; T Kohsaka; H Yagita; K Okumura; M Azuma
View articletitled, Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Open the PDF for in another window
Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine.
C Haas; G Strauss; G Moldenhauer; R M Iorio; V Schirrmacher
View articletitled, Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine.
Open the PDF for in another window
Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
L Yang; R Hwang; Y Chiang; E M Gordon; W F Anderson; D Parekh
View articletitled, Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Open the PDF for in another window
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
W C Zamboni; C F Stewart; P J Cheshire; L B Richmond; S K Hanna; X Luo; C Poquette; J P McGovren; J A Houghton; P J Houghton
View articletitled, Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
Open the PDF for in another window
Synergistic effects of 8-chlorocyclic-AMP and retinoic acid on induction of apoptosis in Ewing's sarcoma CHP-100 cells.
R K Srivastava; A R Srivastava; Y S Cho-Chung
View articletitled, Synergistic effects of 8-chlorocyclic-AMP and retinoic acid on induction of apoptosis in Ewing's sarcoma CHP-100 cells.
Open the PDF for in another window
Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.
S T Palayoor; E A Bump; S K Calderwood; S Bartol; C N Coleman
View articletitled, Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.
Open the PDF for in another window
Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17.
B C Liang; E Ullyatt
View articletitled, Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17.
Open the PDF for in another window
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
W C Zamboni; A J Gajjar; R L Heideman; J H Beijnen; H Rosing; P J Houghton; C F Stewart
View articletitled, Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
Open the PDF for in another window
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
T Vogt; W Stolz; J Welsh; B Jung; R S Kerbel; H Kobayashi; M Landthaler; M McClelland
View articletitled, Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Open the PDF for in another window
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.
B Melichar; C Savary; A P Kudelka; C Verschraegen; J J Kavanagh; C L Edwards; C D Platsoucas; R S Freedman
View articletitled, Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.
Open the PDF for in another window
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
S I Wang; R Parsons; M Ittmann
View articletitled, Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Open the PDF for in another window

Advertisement

Breaking
Pancreatic Cancer Survival Rate Stalls
FDA Bans Red Dye No. 3 in Food
AbbVie Inks Deal for T-Cell Engager
View more recent articles
Latest News
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
Greater Certainty of Survival Valued Over Speedier Drug Access
View more recent articles
Research Watch
Bile Acids Modulate T-cell Response and Function in Liver Cancer
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept